Valuation Joinn Laboratories(China)Co.,Ltd.
Stocks
603127
CNE100002W27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.08 CNY | -3.96% |
|
+3.98% | +5.91% |
Company Valuation: Joinn Laboratories(China)Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 40,246 | 29,328 | 16,313 | 11,374 | 23,924 | 24,926 | - | - |
| Change | - | -27.13% | -44.38% | -30.28% | 110.35% | 4.19% | - | - |
| Enterprise Value (EV) 1 | 36,161 | 26,442 | 13,478 | 10,430 | 23,032 | 23,010 | 22,766 | 22,339 |
| Change | - | -26.88% | -49.03% | -22.61% | 120.83% | -0.1% | -1.06% | -1.88% |
| P/E | 76.4x | 29.2x | 44.7x | 166x | 87.5x | 62.5x | 58.4x | 35.4x |
| PBR | 6.16x | 3.82x | 2.15x | 1.54x | 3.15x | 3.16x | 3.07x | 2.88x |
| PEG | - | 0.3x | -0.7x | -2x | 0x | 1.3x | 8.39x | 0.5x |
| Capitalization / Revenue | 26.5x | 12.9x | 6.86x | 5.64x | 14.4x | 13.6x | 12x | 10.2x |
| EV / Revenue | 23.8x | 11.7x | 5.67x | 5.17x | 13.9x | 12.5x | 11x | 9.12x |
| EV / EBITDA | 50x | 19.8x | 21.5x | 48.8x | 46x | 144x | 60.4x | 30.5x |
| EV / EBIT | 56.2x | 21.6x | 26.6x | 152x | 68x | 724x | 86.5x | 37.9x |
| EV / FCF | 80.6x | 38x | 31.3x | 153x | 76.5x | 62.4x | 99.9x | 102x |
| FCF Yield | 1.24% | 2.63% | 3.19% | 0.65% | 1.31% | 1.6% | 1% | 0.98% |
| Dividend per Share 2 | 0.1837 | 0.2857 | 0.16 | 0.03 | 0.12 | 0.0944 | 0.1154 | 0.38 |
| Rate of return | 0.31% | 0.68% | 0.67% | 0.18% | 0.34% | 0.25% | 0.31% | 1.02% |
| EPS 2 | 0.7704 | 1.429 | 0.53 | 0.1 | 0.4 | 0.5933 | 0.6346 | 1.048 |
| Distribution rate | 23.8% | 20% | 30.2% | 30% | 30% | 15.9% | 18.2% | 36.3% |
| Net sales 1 | 1,517 | 2,268 | 2,376 | 2,018 | 1,658 | 1,836 | 2,076 | 2,448 |
| EBITDA 1 | 723.1 | 1,333 | 626.1 | 213.9 | 500.7 | 159.8 | 376.7 | 732.4 |
| EBIT 1 | 643 | 1,226 | 507.1 | 68.81 | 338.9 | 31.78 | 263.2 | 589.1 |
| Net income 1 | 557 | 1,074 | 397 | 74.08 | 297.8 | 432.7 | 376.6 | 901.5 |
| Net Debt 1 | -4,085 | -2,886 | -2,835 | -943.6 | -891.7 | -1,916 | -2,160 | -2,587 |
| Reference price 2 | 58.89 | 41.72 | 23.71 | 16.63 | 35.01 | 37.08 | 37.08 | 37.08 |
| Nbr of stocks (in thousands) | 747,243 | 749,950 | 746,974 | 733,989 | 733,375 | 733,375 | - | - |
| Announcement Date | 2/24/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 62.49x | 12.53x | 144.03x | 0.25% | 3.66B | ||
| 32.21x | 5.68x | 17.59x | 1.02% | 46.2B | ||
| -22.9x | 343.72x | -21.86x | -.--% | 38.71B | ||
| 23.26x | 2.64x | 11.39x | -.--% | 31.9B | ||
| 41.76x | 4.18x | 26.75x | -.--% | 31.12B | ||
| 27.93x | 7.24x | 18.62x | 0.45% | 23.77B | ||
| 30.92x | 5x | 22.8x | -.--% | 15.05B | ||
| 23.95x | 2.04x | 8.96x | 1.12% | 13.74B | ||
| -22.52x | 14.77x | -22.09x | -.--% | 13.42B | ||
| Average | 21.90x | 44.20x | 22.91x | 0.32% | 24.18B | |
| Weighted average by Cap. | 18.52x | 65.73x | 10.58x | 0.34% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 603127 Stock
- Valuation Joinn Laboratories(China)Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
















